HA
RMD icon

Harbor Advisors’s ResMed RMD Stock Holding History

Harbor Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$292K Hold
1,500
– – 0.04% 163
2026
Q1 		$337K Hold
1,500
– – 0.05% 146
2025
Q4 		$361K Hold
1,500
– – 0.05% 141
2025
Q3 		$411K Hold
1,500
– – 0.06% 135
2025
Q2 		$387K Hold
1,500
– – 0.06% 137
2025
Q1 		$336K Hold
1,500
– – 0.06% 143
2024
Q4 		$343K Buy
+1,500
New +$361K 0.05% 143

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Harbor Advisors's RMD Position: Q2 2026 in Review

Harbor Advisors held its ResMed (RMD) position steady in Q2 2026 at 1,500 shares worth $292K. The position accounts for 0.04% of the portfolio, ranked #163.

Harbor Advisors first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $411K in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Harbor Advisors held 1,500 shares of ResMed worth $292K as of Q2 2026.
  • Harbor Advisors left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.04% of Harbor Advisors's portfolio in Q2 2026, its #163 holding.
  • Harbor Advisors first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • Harbor Advisors's ResMed position peaked at $411K in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Harbor Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.